IQVIA Holdings Inc (IQV)
IQVIA Holdings Inc (IQV) carries a ŷRobot AI score of 69 out of 100. The model's fair value estimate is $278.74, 5.1% above the last close of $265.12. The chart signal reads Bullish.
| Metric | IQV |
|---|---|
| AI score | 69 / 100 |
| Chart signal | Bullish |
| Fair value estimate | $278.74 |
| Upside to fair value | 5.1% |
| Previous close | $265.12 |
| P/E | 33.48 |
| Price / sales | 2.62 |
| Market cap | $45.24B |
| EPS | 8.22 |
| Revenue growth | 4.0% |
| 1-year price change | 5.5% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about IQV
Is IQV overvalued or undervalued right now?
As of Oct 30, 2026, ŷRobot's fair-value model estimates IQVIA Holdings Inc (IQV) at $278.74 against a last close of $265.12, implying 5.1% upside to the model's estimate.
Is IQV's chart signal bullish or bearish?
The chart-signal model classifies IQV as Bullish as of Nov 13, 2026, with a signal score of 0.16 on a -1 to 1 scale.
What is IQV's ŷRobot AI score?
IQV scores 69 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is IQV stock expensive on P/E and P/S?
IQV trades at 33.5 times earnings and 2.6 times sales as of Nov 13, 2026.
What does IQV's seasonal forecast show?
ŷRobot's seasonal forecast curve for IQV reads +2.1% at 30 days, +2.1% at 90 days, and +5.5% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is IQV growing?
IQVIA Holdings Inc's revenue growth is +4.0% and free-cash-flow growth is -5.2% on the latest reported figures.
IQV chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.